Literature DB >> 15939554

Genomic structure and functional characterization of the promoter region of human IkappaB kinase-related kinase IKKi/IKKvarepsilon gene.

Naizhen Wang1, Salahuddin Ahmed, Tariq M Haqqi.   

Abstract

The inducible IkappaB kinase (IKKi/IKKepsilon) is a recently described serine-threonine kinase that activates the transcription factors NFkappaB, interferon regulatory factor-3 (IRF3) and CCAAA/enhancer-binding protein (C/EBPdelta). Several inflammatory agents have been shown to induce the expression of the IKKi gene in macrophages and other cell types but the mechanism is unknown. We have found that the IKKi expression was constitutive in human chondrocytes from OA cartilage and a human chondrocytic cell line C28/I2 but was up-regulated by the inflammatory cytokines TNFalpha or IL-1betain an NFkappaB-dependent manner. To understand the constitutive and inducible expression of the IKKi gene we localized the transcription start site (TSS), cloned and sequenced a 2 kb genomic DNA fragment 5' of the TSS and characterized the putative promoter region (PPR), and identified the motifs therein that are required for basal and cytokine-induced IKKi gene promoter activity. We found that IKKi core promoter was TATA-less and by using PCR generated deletion mutants of the PPR we found that the cis-elements responsible for basal transcriptional activity were located between -51 and -100 bp upstream of the TSS while the cytokine response elements were located distally between -501 and -1000 bp upstream of the TSS. The DNA region containing the cytokine response elements had two kappaB sites as the most relevant regulatory motifs. The results of site-directed mutagenesis revealed that the kappaB site located between -833 and -847 bp upstream of the TSS was biologically functional and required for cytokine-induced IKKi promoter activity in human chondrocytes and HeLa cells. The silence of the other kappaB site (-816/-802) was positional, rather than sequence-specific. Over-expression of NFkappaB p65 mimics the TNFalpha-induced activation of the IKKi promoter. Also the gel shift assay suggested that NFkappaB p65 is responsible for activation of the IKKi promoter. These data for the first time characterize the promoter region and provide further insights into the transcriptional regulation of IKKi in human chondrocytes and other cell types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939554      PMCID: PMC1266289          DOI: 10.1016/j.gene.2005.04.013

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  40 in total

1.  IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex.

Authors:  R T Peters; S M Liao; T Maniatis
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

Review 2.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

3.  IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2.

Authors:  Nandini Kishore; Q Khai Huynh; Sumathy Mathialagan; Troii Hall; Sharon Rouw; David Creely; Gary Lange; James Caroll; Beverley Reitz; Ann Donnelly; Hymavathi Boddupalli; Rodney G Combs; Kuniko Kretzmer; Catherine S Tripp
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

4.  Identification and characterization of the potential promoter regions of 1031 kinds of human genes.

Authors:  Y Suzuki; T Tsunoda; J Sese; H Taira; J Mizushima-Sugano; H Hata; T Ota; T Isogai; T Tanaka; Y Nakamura; A Suyama; Y Sakaki; S Morishita; K Okubo; S Sugano
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

5.  Triggering the interferon antiviral response through an IKK-related pathway.

Authors:  Sonia Sharma; Benjamin R tenOever; Nathalie Grandvaux; Guo-Ping Zhou; Rongtuan Lin; John Hiscott
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

6.  Two pathways to NF-kappaB.

Authors:  Joel L Pomerantz; David Baltimore
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

7.  Kinetic mechanisms of IkappaB-related kinases (IKK) inducible IKK and TBK-1 differ from IKK-1/IKK-2 heterodimer.

Authors:  Q Khai Huynh; Nandini Kishore; Sumathy Mathialagan; Ann M Donnelly; Catherine S Tripp
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

8.  Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes.

Authors:  K R Aupperle; Y Yamanishi; B L Bennett; F Mercurio; D L Boyle; G S Firestein
Journal:  Cell Immunol       Date:  2001-11-25       Impact factor: 4.868

9.  NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation.

Authors:  F Nomura; T Kawai; K Nakanishi; S Akira
Journal:  Genes Cells       Date:  2000-03       Impact factor: 1.891

10.  IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli.

Authors:  Vladimir V Kravchenko; John C Mathison; Klaus Schwamborn; Frank Mercurio; Richard J Ulevitch
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

View more
  11 in total

1.  Regulation of IKKε Expression by Akt2 Isoform.

Authors:  Soumya Krishnamurthy; Alakananda Basu
Journal:  Genes Cancer       Date:  2011-11

2.  Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.

Authors:  D Bauer; N Redmon; E Mazzio; E Taka; J S Reuben; A Day; S Sadrud-Din; H Flores-Rozas; K F A Soliman; S Darling-Reed
Journal:  Cytokine       Date:  2015-06-20       Impact factor: 3.861

3.  IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.

Authors:  J Guo; D Kim; J Gao; C Kurtyka; H Chen; C Yu; D Wu; A Mittal; A A Beg; S P Chellappan; E B Haura; J Q Cheng
Journal:  Oncogene       Date:  2012-02-13       Impact factor: 9.867

Review 4.  The interferon inducing pathways and the hepatitis C virus.

Authors:  Eliane F Meurs; Adrien Breiman
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

5.  IKKε knockout prevents high fat diet induced arterial atherosclerosis and NF-κB signaling in mice.

Authors:  Changchun Cao; Yifan Zhu; Wen Chen; Liangpeng Li; Yongchao Qi; Xiaodi Wang; Ye Zhao; Xin Wan; Xin Chen
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

6.  IKKα negatively regulates ASC-dependent inflammasome activation.

Authors:  Bradley N Martin; Chenhui Wang; Jami Willette-Brown; Tomasz Herjan; Muhammet F Gulen; Hao Zhou; Katarzyna Bulek; Luigi Franchi; Takashi Sato; Emad S Alnemri; Goutham Narla; Xiao-Ping Zhong; James Thomas; Dennis Klinman; Katherine A Fitzgerald; Michael Karin; Gabriel Nuñez; George Dubyak; Yinling Hu; Xiaoxia Li
Journal:  Nat Commun       Date:  2014-09-30       Impact factor: 14.919

7.  Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorder.

Authors:  Tanel Traks; Kati Koido; Roman Balõtšev; Triin Eller; Sulev Kõks; Eduard Maron; Innar Tõru; Jakov Shlik; Eero Vasar; Veiko Vasar
Journal:  Brain Behav       Date:  2015-02-13       Impact factor: 2.708

8.  IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.

Authors:  Jia Dai; Di-Fei Shen; Zhou-Yan Bian; Heng Zhou; Hua-Wen Gan; Jing Zong; Wei Deng; Yuan Yuan; FangFang Li; Qing-Qing Wu; Lu Gao; Rui Zhang; Zhen-Guo Ma; Hong-Liang Li; Qi-Zhu Tang
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

Review 9.  IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer.

Authors:  Kelly Verhelst; Lynn Verstrepen; Isabelle Carpentier; Rudi Beyaert
Journal:  Biochem Pharmacol       Date:  2013-01-17       Impact factor: 5.858

10.  Dynamic chromatin accessibility landscape changes following interleukin-1 stimulation.

Authors:  Matt J Barter; Kathleen Cheung; Julia Falk; Andreas C Panagiotopoulos; Caitlin Cosimini; Siobhan O'Brien; Karina Teja-Putri; Graham Neill; David J Deehan; David A Young
Journal:  Epigenetics       Date:  2020-08-02       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.